CoChat

Androgen sensitivity gateway to COVID‐19 disease severity

Open access
Wambier, Carlos Gustavo, Goren, Andy, Vaño‐Galván, Sergio, Ramos, Paulo Müller, Ossimetha, Angelina, Nau, Gerard, Herrera, Sabina, McCoy, John · 2020 · Drug Development Research
Cited by 164

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

In this communication, we present arguments for androgen sensitivity as a likely determinant of COVID‐19 disease severity. The androgen sensitivity model explains why males are more likely to develop severe symptoms while children are ostensibly resistant to infection. Further, the model explains the difference in COVID‐19 mortality rates among different ethnicities. Androgen sensitivity is determined by genetic variants of the androgen receptor. The androgen receptor regulates transcription of the transmembrane protease, serine 2 (TMPRSS2), which is required for SARS‐CoV‐2 infectivity. TMPRSS2 primes the Spike protein of the virus, which has two consequences: diminishing viral recognition by neutralizing antibodies and activating SARS‐CoV‐2 for virus‐cell fusion. Genetic variants that have been associated with androgenetic alopecia, prostate cancer, benign prostatic hyperplasia and polycystic ovary syndrome could be associated with host susceptibility. In addition to theoretical epidemiological and molecular mechanisms, there are reports of high rates of androgenetic alopecia of from hospitalized COVID‐19 patients due to severe symptoms. Androgen sensitivity is a likely determinant of COVID‐19 disease severity. We believe that the evidence presented in this communication warrants the initiation of trials using anti‐androgen agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ddr.21688

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Metadata

Authors
Wambier, C. G., Goren, A., Vaño‐Galván, S., Ramos, P. M., Ossimetha, A., Nau, G., Herrera, S., & McCoy, J.
Venue
Drug Development Research
Publisher
Wiley
Published
2020-05-15
Volume
81
Issue
7
Pages
771-776
ISSN
  • 0272-4391 (ISSN-L)
  • 1098-2299
OpenAlex
W3025990187
Cited by
164
References
36
FWCI
4.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Androgen sensitivity gateway to COVID‐19 disease severity. https://app.cochat.ai/papers/10.1002/ddr.21688
The paper
Wambier, C. G., Goren, A., Vaño‐Galván, S., Ramos, P. M., Ossimetha, A., Nau, G., Herrera, S., & McCoy, J. (2020). Androgen sensitivity gateway to COVID‐19 disease severity. Drug Development Research. https://doi.org/10.1002/ddr.21688

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.